Published in PLoS One on March 27, 2015
Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy - Where to from Here? Front Neurol (2015) 0.86
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci (2015) 0.84
Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges. Semin Perinatol (2016) 0.83
Mesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity? Mol Cell Pediatr (2016) 0.80
Oxidative Stress in Hypoxic-Ischemic Encephalopathy: Molecular Mechanisms and Therapeutic Strategies. Int J Mol Sci (2016) 0.79
Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges. Front Cell Neurosci (2017) 0.76
Stem Cell Therapy for Neonatal Disorders: Prospects and Challenges. Yonsei Med J (2017) 0.75
Neuroprotective Effects of Acetyl-L-Carnitine on Neonatal Hypoxia Ischemia-Induced Brain Injury in Rats. Dev Neurosci (2017) 0.75
Role of Antioxidants in Neonatal Hypoxic-Ischemic Brain Injury: New Therapeutic Approaches. Int J Mol Sci (2017) 0.75
Combination of butylphthalide with umbilical mesenchymal stem cells for the treatment of delayed encephalopathy after carbon monoxide poisoning. Medicine (Baltimore) (2016) 0.75
Neurological consequences of systemic inflammation in the premature neonate. Neural Regen Res (2017) 0.75
Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med (2005) 13.96
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells (2006) 8.61
Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med (2009) 7.94
Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev (2007) 3.42
Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics (2007) 2.64
Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci (2005) 1.77
Term infants with hypoxic-ischemic encephalopathy: outcome at 3.5 years. Dev Med Child Neurol (1985) 1.69
Whole-body hypothermia for neonatal encephalopathy: animal observations as a basis for a randomized, controlled pilot study in term infants. Pediatrics (2002) 1.66
Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy (2004) 1.59
Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke (2010) 1.44
The adolescent brain and the college drinker: biological basis of propensity to use and misuse alcohol. J Stud Alcohol Suppl (2002) 1.41
Influence of age on the cerebral lesions in an immature rat model of cerebral hypoxia-ischemia: a light microscopic study. Brain Res Dev Brain Res (1997) 1.39
Metabolic downregulation: a key to successful neuroprotection? Stroke (2008) 1.33
Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am J Obstet Gynecol (2011) 1.31
IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev (2005) 1.23
Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr Res (2012) 1.18
Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol (2006) 1.16
Animal models of perinatal hypoxic-ischemic brain damage. Pediatr Neurol (2009) 1.13
Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun (2009) 1.13
Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS One (2013) 1.12
Cerebral hypothermia for prevention of brain injury following perinatal asphyxia. Curr Opin Pediatr (2000) 1.07
Immediate hypothermia is not neuroprotective after severe hypoxia-ischemia and is deleterious when delayed by 12 hours in neonatal rats. Stroke (2012) 1.04
Comparison of two neonatal ischemic injury models using magnetic resonance imaging. Pediatr Res (2007) 1.01
Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage. Stroke (2013) 1.00
Hypoxic and ischemic disorders of infants and children. Lecture for 38th meeting of Japanese Society of Child Neurology, Tokyo, Japan, July 1996. Brain Dev (1997) 0.93
Neuroprotective effect of cycloheximide on hypoxic-ischemic brain injury in neonatal rats. J Korean Med Sci (2006) 0.88
Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res (2012) 0.88
Long-term neuroprotective effect of postischemic hypothermia in a neonatal rat model of severe hypoxic ischemic encephalopathy: a comparative study on the duration and depth of hypothermia. Pediatr Res (2010) 0.87
Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr (2014) 1.64
High-dose enzyme replacement therapy attenuates cerebroventriculomegaly in a mouse model of mucopolysaccharidosis type II. J Hum Genet (2013) 1.41
Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury. Cytotherapy (2015) 0.83
Optimal Route for Mesenchymal Stem Cells Transplantation after Severe Intraventricular Hemorrhage in Newborn Rats. PLoS One (2015) 0.82
A novel PRF1 gene mutation in a fatal neonate case with type 2 familial hemophagocytic lymphohistiocytosis. Korean J Pediatr (2014) 0.82
Optimal Route for Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation to Protect Against Neonatal Hyperoxic Lung Injury: Gene Expression Profiles and Histopathology. PLoS One (2015) 0.80
Permissive hyperglycemia in extremely low birth weight infants. J Korean Med Sci (2013) 0.77
Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage. Korean J Pediatr (2014) 0.76
Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation. J Korean Med Sci (2015) 0.76
Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia. J Korean Med Sci (2015) 0.76
Stem Cells for Neonatal Brain Disorders. Neonatology (2016) 0.76
Quantitative in vivo detection of brain cell death after hypoxia ischemia using the lipid peak at 1.3 ppm of proton magnetic resonance spectroscopy in neonatal rats. J Korean Med Sci (2013) 0.75
Intratracheal transplantation of mesenchymal stem cells simultaneously attenuates both lung and brain injuries in hyperoxic newborn rats. Pediatr Res (2016) 0.75
Prevention of Cytomegalovirus Transmission via Breast Milk in Extremely Low Birth Weight Infants. Yonsei Med J (2015) 0.75
A Novel De Novo Pathogenic Variant in FOXF1 in a Newborn with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins. Yonsei Med J (2017) 0.75
Stem Cell Therapy for Neonatal Disorders: Prospects and Challenges. Yonsei Med J (2017) 0.75
Intraventricular Hemorrhage and Post Hemorrhagic Hydrocephalus among Very-Low-Birth-Weight Infants in Korea. J Korean Med Sci (2015) 0.75
Gene Profiles in a Smoke-Induced COPD Mouse Lung Model Following Treatment with Mesenchymal Stem Cells. Mol Cells (2016) 0.75
Permissive hypotension in extremely low birth weight infants (≤1000 gm). Yonsei Med J (2012) 0.75
The Youngest Survivor with Gestational Age of 21⁵/₇ Weeks. J Korean Med Sci (2018) 0.75
MERS-CoV Infection in a Pregnant Woman in Korea. J Korean Med Sci (2017) 0.75
Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams. J Korean Med Sci (2017) 0.75